Company Profile
Q32 Bio Inc Stock Price, News & Analysis
- Ticker:
- QTTB
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
15.21 USD (+0.40%)
Close
Last updated: July 27, 2026
214M USD
Market cap
Why the stock is moving
As of Jul 27, 2026, QTTB closed up 0.40% at $15.21. No new same-company headline was identified in the current news window.
Company overview
Business overview
Q32 Bio is a biotechnology company focused on inflammation and immune modulation through complement or related pathways. Its story is built around targeting hard immune-mediated diseases with a specific biological mechanism.
Geographic Base and Sector Classification
Q32 Bio is headquartered in the United States and listed on NASDAQ. It sits in specialty immunology biotechnology.
Business Model Characteristics
The company depends on clinical validation, translational progress, and the ability to keep a narrow pipeline funded. Investors usually watch early data and strategic changes.
Position Within the Biotechnology Landscape
Q32 occupies a niche immunology position within biotech. It is catalyst-sensitive because the market needs proof that the pathway can create real clinical differentiation.
Future catalysts
Q32 Bio's catalysts are bempikibart's alopecia-areata Phase 2 readout, the ongoing SIGNAL-AA / SIGNAL-AD program cadence, and any strategic decision around the complement platform. The company still needs each clinical step to show that the IL-7Rα story is moving from a promising signal into a durable immune-disease franchise.
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Kymera Therapeutics Appoints Terence Rooney, MD, as Chief Medical Officer
KYMR · Source: Kymera
- 02
- 03
- 04
- 05
Avalo Therapeutics to Participate in the BTIG Biotechnology Conference
AVTX · Source: Avalo Therapeutics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Q32 Bio Inc (QTTB)?
Q32 Bio Inc (QTTB) most recently closed at 15.21 USD, a +0.40% move versus the previous session.
What is the market cap of Q32 Bio Inc (QTTB)?
Q32 Bio Inc currently has a market capitalization of 214M USD on BioPharmSignal.
What does Q32 Bio Inc do?
Q32 Bio is a biotechnology company focused on inflammation and immune modulation through complement or related pathways. Its story is built around targeting hard immune-mediated diseases with a specific biological mechanism.
On which exchange is QTTB stock listed?
Q32 Bio Inc (QTTB) is associated with NASDAQ, United States, Biopharma.
What is SIGNAL-AA?
Q32 Bio's catalysts are bempikibart's alopecia-areata Phase 2 readout, the ongoing SIGNAL-AA / SIGNAL-AD program cadence, and any strategic decision around the complement platform.
Which conditions is Q32 Bio Inc targeting with SIGNAL-AA?
Q32 Bio Inc is associated with inflammatory disease based on its company overview and current catalyst commentary.
How does Q32 Bio Inc describe recent progress with SIGNAL-AA?
Q32 Bio's catalysts are bempikibart's alopecia-areata Phase 2 readout, the ongoing SIGNAL-AA / SIGNAL-AD program cadence, and any strategic decision around the complement platform.
What is SIGNAL-AD?
Q32 Bio's catalysts are bempikibart's alopecia-areata Phase 2 readout, the ongoing SIGNAL-AA / SIGNAL-AD program cadence, and any strategic decision around the complement platform.